The Urgency to Approve Govorestat For the Treatment of Galactosemia

(1:57)

Govorestat for CMT-SORD: Designing a Clinical Trial for a Slow Progressing CMT

(17:16)

The drug development process Govorestat and the INSPIRE clinical trial for CMT SORD

(1:2:48)

Efficacy of Govorestat to Treat Galactemia

(5:42)

APLT surges over 60% as FDA skips Advisory Committee for govorestat,

(2:47)

Applied Therapeutics: An Overview

(1:46)

The Galactosemia community asks the FDA to approve their first ever treatment

(4:36)

SORD Deficiency Explained

(4:23)

Shareholder Alert for Applied Therapeutics (APLT)

(1:)

Investor Class Action Filed Against Applied Therapeutics (APLT) for Securities Fraud Violations

(1:15)

New Handbook for Type 1 Galactosemia

(5:10)

Galactosemia Patient-Focused Drug Development (PFDD) Meeting

(1:19)

The Pathophysiology of Galactosemia

(5:58)

What is Galactosaemia? By Stacey Geard

(5:15)

Kayla's Galactosemia Journey

(4:7)

Behind the Bell: Applied Therapeutics

(6:14)

Galactosemia Family Story: Megan and Ava

(3:43)